Before the Starting Gun: What UK Athletes Should Verify About CBD and Anti-Doping

The gym locker is an unglamorous place to make a decision about anti-doping, but it is where many of them are made. A balm goes into a kit bag, a bottle of drops goes into a shaker-side pocket, and nobody thinks twice until a doping control officer appears. For UK athletes, CBD deserves a little more care than that, not because the molecule is banned, but because the products containing it are not held to any single standard.

Clearing up the central misconception

Cannabidiol has been absent from the World Anti-Doping Agency's prohibited list since 2018, and UK Anti-Doping applies the same position. So far, so straightforward. The complication is that CBD is not the only cannabinoid in a cannabis extract, and several others — tetrahydrocannabinol (THC) most obviously, but also related compounds — remain prohibited in competition.

That distinction matters because of strict liability. Under the anti-doping framework, an athlete is responsible for whatever is found in their sample. Intent is not the test. A product bought in good faith from a reputable-looking shop, described as 'THC-free', is not a defence if a laboratory finds a prohibited metabolite.

Why 'THC-free' is a weaker promise than it sounds

The phrase has no single legal definition in the UK consumer market. In practice, it usually means that a given laboratory, using a given method, did not detect THC above its limit of quantification. Change the laboratory, the method or the batch, and the assurance may not travel.

What an athlete actually needs is batch-specific evidence. That means a certificate of analysis where the batch number printed on the report matches the batch number on the pack; the testing laboratory is identifiable and, ideally, accredited to ISO 17025; the method and limit of quantification are stated; and the results report total THC, including any acidic precursor that may convert over time. A generic certificate, undated and unnumbered, tells you something about a product in principle and very little about the bottle in your hand.

Ingested and topical products are not the same risk

Route of administration deserves more attention than it usually receives. Oral drops, capsules, edibles and drinks deliver cannabinoids systemically, which is precisely why they attract the most scrutiny. Vaped products raise further questions, not least because inhaled CBD has no authorised supply route in the UK.

Topical balms and salves are generally formulated for local use, and absorption through intact skin is limited. That is a reason for proportion, not complacency. Products marketed as 'transdermal' may include penetration enhancers intended to push ingredients further into the skin, and broken or inflamed skin absorbs more than intact skin. There is also very little published data on how much of a topical CBD product reaches the bloodstream in real-world use. Treat 'it's only a rub' as a reasonable intuition rather than a guarantee.

A checklist worth keeping in the kit bag

1. Identify what the product actually is. In the UK, CBD on the high street is usually sold as a cosmetic or a food supplement, not as a licensed medicine. The regulatory category tells you what claims the seller is permitted to make, and it tells you something about the level of scrutiny involved.
2. Ask for the batch certificate, not the brand certificate. Check the batch number, the date, the laboratory and the limit of quantification. If a retailer cannot supply it, that is information in itself.
3. Look past cannabinoids. Unregulated supply chains carry wider contamination risks. Ask what else the panel screened for.
4. Keep a record. Product name, batch number, certificate date, daily amount used, dates of use, and the receipt. If a query ever arises, a contemporaneous record is worth considerably more than a recollection.
5. Declare it on the doping control form. There is a section for supplements and medications. Declaring a product does not excuse an adverse finding, but it is recorded and can inform the review of a case.
6. Do not expect a therapeutic use exemption. A TUE is for prohibited substances with a genuine medical need. Since CBD is not prohibited, there is nothing to exempt.
7. Speak to your club doctor or a sports medicine clinician. If CBD is being used to manage pain, sleep or anxiety, it is worth asking whether a better-evidenced option exists.

On 'WADA-approved' products

There is no such thing. WADA does not certify, approve or endorse commercial products, and any brand implying otherwise should be treated with scepticism. Third-party testing schemes exist, but they are commercial assurance programmes with their own scope and limitations, not a regulatory seal.

If an adverse finding happens

The process is not designed to be comfortable. An athlete can request analysis of the B sample, and the review will examine the circumstances and the documentation. A label is not a defence; a certificate that does not match the batch is close to worthless. What carries weight is a coherent account supported by records and, where possible, independent testing of the product itself.

What this article is not

It is not a recommendation to use CBD, and it is not a suggestion that athletes should avoid a legitimately permitted substance out of excessive caution. It is an argument for asking better questions at the point of purchase — before the product is in the locker, and long before the start line.